In 1885, Martin29 mentions a paper of Ringer and Murrell42 published in 1883 advocating manganese salts in treating amenorrhea. He also quotes Broadbent's observation' that ". . . manganese seemed to have a special influence in promoting the return of the catamenia . . ." Martin, himself, reported28 success in treating amenorrhea with manganese in 1883, and in 1885 he presented case records illustrating similar success in treating menorrhagia and metrorrhagia.29 Upshur50 testified, in 1887, to the value of manganese in menstrual disorders, including membranous dysmenorrhea.
Two years later O'Donovan published "A Plea for the Use of the Manganese Compounds in Certain Forms of Dysmenorrhea," presenting several case histories supporting his claim that manganese dioxide would entirely relieve from pain the majority of women suffering with primary dysmenorrhea.32 In this, and in two subsequent papers33' 3 he discusses dosage, and the indications for and * From the Department of Pharmacology and Toxicology, Yale University School of Medicine. Based on a Thesis prepared in candidacy for the Degree of Doctor of Medicine. results of manganese medication in dysmenorrhea. He observed no deleterious effect of the drug, even after long-continued use.
No later reports of this nature have been found, except for such non-committal notes as that in the U. S. Dispensatory:5' "The salt (MnO2) seems to possess some stimulant action on the uterine mucosa and is still used in the treatment of amenorrhea," and Bastedo's comment' that "Manganese dioxide and potassium permanganate have a reputation as emmenogogues." von Oettingen's study35 of the pharmacology of manganese contains an exhaustive review of the literature up to 1935, except that the early use of manganese in menstrual disorders is omitted.
Manganese is a familiar catalyst in inorganic chemistry, is a constant and important constituent of plants, and, in animals, small concentrations increase antitoxin formation, liver autolysis, and cell respiration.
Studies by Reiman and Minot" indicate that absorption of manganese oxides and silicates from the normal digestive tract is very slow and incomplete, depending largely on the acidity of the gastric juice. The subsequent rise in the blood level never exceeds twice the normal manganese content of the blood (which averaged 0.013 mg. % in 14 cases, varying from 0.005 to 0.023 mg. %.). Elimination of manganese from the blood is very rapid, and the toxicity of ingested manganese ores is very low.
The distribution of manganese after ingestion is mainly to the liver, but after injection, intraperitoneal or subcutaneous, there is a marked increase in the manganese content of the brain. It is stored mainly in the liver, and is excreted in the feces, probably by the colon, though partly in the bile. Urinary excretion is minimal.
The toxic effects of manganese occurring after inhalation of manganese dust have often been described. A typical Parkinsonian syndrome is observed and the pathological lesions are found mainly in the putamen, caudate nuclei, and globus pallidus. The similarity of the lesions to those of carbon monoxide poisoning is significant, in view of Sato' s observation that toxic doses of manganese act by depressing tissue oxidation. Similar lesions have been produced in animals by parenteral injection of manganese, but they are not seen after oral ingestion until the liver has first been severely damaged by the manganese.
Working with concentrations of MnCI2 of 20 to 40 mg. %, Dodel'6 concluded that manganese exerted an unselective effect on the autonomic nervous system, but he was probably only observing an unselective depressant effect of manganese in toxic doses on tissue metabolism in general.
de Jongh24 investigated a possible abortifacient effect of potassium permanganate and concluded that this effect was dependent on the oxidizing power of the molecule, not on the manganese. Small concentrations of MnCl2 and MnSO4 had no effect on the isolated guinea-pig uterus.
Various studies bearing on the influence of manganese on physiological processes have been reported, such as those of Sato,44 who concluded that manganese was a catalyst of cell oxidative processes, and of Waddel, Steenbock, and Hart51 on the effects of manganesedeficient diets on the growth, reproduction, and ovulation of rats. The abnormalities reported by these workers could not be substantiated by Orent and McCollum.", 8 Skinner, Van Donk, and Steenbock46 affirmed that manganese is essential to normal estruc, McCollum et al.27 described testicular degeneration in rats maintained upon a manganese-deficient diet, and Daniels and Everson14 noted a "congenital debility" in the offspring of rats kept on a similar diet.
The once popular use of manganese in the treatment of the anemias has been discontinued, and its use in dermatology has been condemned by the Council on Pharmacy and Chemistry of the American Medical Association.8
Nevertheless, it has recently been shown (Cowgill9' 10) that manganese is essential to the activity of thiamin, and Perla and Sandberg"8 believe that manganese acts with thiamin as an oxidative wtalyst and that the toxic effects of excess thiamin are really due to lack of manganese. The tissues of birds with beri-beri are low in manganese (Hamamoto22), the ascorbic acid content of growing seeds is increased by manganese (Rudra43), sugar oxidation is accelerated by small amounts of manganese (Bodansky3), and Nott3" reports the cure of four cases of parenchymatous goiter by the use of potassium permanganate enemata.
Such is some of the evidence pointing to the r6le, or rOles, which manganese may play. Dysmenorrhea "Primary," "idiopathic," and "non-surgical" are designations for the type of dysmenorrhea in which manganese seems to be most effective and with which this study deals. Curtis"3 mentions the work of Novak and Reynolds supporting their contention that, whatever the underlying cause of dysmenorrhea may be, the actual pain results from a spasmodic contraction of the uterine muscle. The action of theelin to excite rhythmic uterine contractions and of progestin to inhibit them is reviewed, and the now familiar theory of theelin excess (or progestin lack) as causing dysmenorrhea is proposed. Fluhmann Wendel,52 after Hertzler, describes a condition he calls "goiterous dysmenorrhea" or "interstitial thyrotoxicosis," presumably producing "mild, chronic hyperthyroidism," not demonstrable by changes in the basal metabolic rate. The thyroids are found to be large, red-brown, and rubbery and most of the patients live in the mid-west goiter belt. It seems at least as likely that these patients have dysmenorrhea because their thyroids are underfunctioning during menstruation as it does that they have mild hyperthyroidism. Potassium iodide was used with success in treating these cases.
Hypothesis
The following argument is presented as a basis for the present thesis.
Whether or not spasm of the uterus occurs in dysmenorrhea is of little importance, unless such spasm can be shown to be the cause of the pain. Further, one must avoid the error of calling exaggerated contractions spasm. Even a maximal contraction in a normally functioning skeletal muscle is known not to cause pain unless it actually traumatizes tissue. Conversely, pain is frequently encountered in muscle, after severe exercise, where there is no evidence of spasm. Pain is, moreover, frequently seen in muscle exercized in the face of an inadequate blood supply. Intermittent claudication, swimmers' cramps, and perhaps angina pectoris are familiar examples of this. Boland4 has published a report of his success in relieving the pain of coronary thrombosis and angina pectoris by administering oxygen. He feels that this supports Lewis's contention26 that the pain arising in ischemic muscle is the result of oxygen lack. Fluhmann17 quotes Markee, and also Moir, as attributing dysmenorrhea to constriction of the vessels of the uterus with resulting ischemia and oxygen lack. O'Donovan32 commented in his first paper that many cases of dysmenorrhea associated with chlorosis and other secondary anemias clear up when the anemia (and resulting anoxemia) are relieved.
Granting, then, that anoxia in exercizing muscle can cause pain, it is helpful, as a working hypothesis, to adopt Lewis's proposal that the immediate cause of anoxial pain is chemical irritation produced by the presence of products of contraction, such as lactic acid. Removal of these products could be hastened not only by supplying oxygen, but also by increasing the enzyme-activated processes of internal respiration. Indeed, failure of these processes, as well as anoxia, might in some cases be responsible for pain in muscle.
The three agents (excluding anodynes and surgical measures or measures inhibiting ovulation) perhaps most successfully used to treat dysmenorrhea, namely, manganese, thyroid extract, and potassium iodide, all act, directly or indirectly, as catalysts of cellular oxidative processes.
Admittedly, these catalysts of cell oxidative processes, manganese and thyroxine (and iodine.through thyroxine), affect organs other than the uterus. Their importance, for example, in maintaining normal ovarian function is especially prominent and it may be that their effect on dysmenorrhea is indirect. The hypothesis which this study is intended to test is: that the pain which is dysmenorrhea is caused by some failure of the oxidative processes of uterine muscle and that manganese (and thyroxine) if they relieve that pain are acting as oxidative catalysts, improving the internal respiration of the muscle tissue.
Materials and methods
The experiments were planned to demonstrate whether or not manganese has a direct, favorable action on the mechanics of uterine contraction. Attempts were also made to show whether or not the thyroid gland may exert similar effects. In addition, the effects of a double deficiency, of manganese and iodine, on the action of the uterus were investigated in view of the suggestion5' that these elements may be complementary.
Diets and preparation:
Thirty-three young, normal, non-pregnant, albino rats were placed on one of three diets; 15 were fed a control diet adequate in all essentials, 12 were deprived as far as possible of manganese, and the remaining 6 were deprived of both manganese and iodine. All received only distilled water to drink. The cages were so constructed that coprophagy was impossible. Some animals were thyroidectomized.
The diet* was modeled after that on which Daniels and Everson' raised 5 consecutive generations of normal rats. By eliminating the added manganese from this diet they were able to produce signs of manganese deficiency ("congenital debility"). The young of rats on such a diet contained 65 per cent less manganese in their tissues than those of normal rats. Except in the first few experiments, in which Tyrode's solution was used, the following technic was employed in investigating the activity of the uteri and the effect of pitocin and manganese. The rats were kflled and the entire uterus dissected free of mesentery and ovaries. Equal and symmetrical portions of the two horns were then isolated and adjusted for recording contractions.
The effect of MnCl2 in varying concentrations on these contractions and on the contractions produced by various dilutions of pitocin was then studied. Manganese was used as the chloride, MnCl2, certain convenient dilutions having been made up with doubly distilled water at the beginning of the study and used throughout. Solutions were used of such concentrations that the introduction of a very few drops would bring about the desired concentration of manganese in the bath, without significantly altering the concentration of the salts in the Ringer-Locke solution.
Results Figure 1 presents the average weight curves of the three diet groups, excluding the weights of the thyroidectomized rats and of a rat with a huge tumor. The rats on the manganese-deficient diet gained as well as the controls, an observation in keeping with the reports of others,27 but the rats deprived of both manganese and iodine exhibited a significant lag in growth. Rats 6-R and 10-R developed tumors and rats 4-L and 5-R became malnourished, for reasons not evident. The thyroids of all the rats were examined grossly and in no instance appeared abnormal.
The experiments done on 16 of the rats in this series were so conducted that the results may be compared, and it is from these that the findings are drawn. The 16 rats are divided into groups of 4 each, one group having been thyroidectomized, one deprived of manganese, one deprived of manganese and iodine, and one serving as a control group receiving the complete diet. In every case, both uterine horns were used and studied separately, though simultaneously, so that for practical purposes, 32 experiments are represented. The recording periods in each experiment averaged about 4>2 hours. Spontaneous activ'ty: The degree of spontaneous activity in each uterus was determined by counting the contractions in a I 0-minute period. The figures so obtained are presented in Table 1 . It is apparent that various degrees of activity occurred in each of the 4 groups of rats studied. This is to be expected, since no attempt was made to sacrifice the rats in comparable stages of estrus, and it is known that the spontaneous rhythmic contractions of the uterus vary markedly with the estrual cycle.25
Manganese and spontaneous activity: Dodel has shown that very high concentrations of manganese (20 mg. % and above) depress spontaneous activity, and it was easy to confirm this observation. Low concentrations of manganese, such as have been produced in the blood stream by the oral ingestion of manganese salts,4" were found to have no significant effect on spontaneous activity. In fact, even concentrations exceeding 20 times the highest reported blood level were ineffectual. In 29 instances, each time with a different specimen, MnCI2, in concentrations ranging from 0.02 to 0.8 mg. %, was introduced to a fresh, spontaneously contracting uterus. In 24 of these cases it was clear that the manganese did not significantly alter the tone, amplitude, or frequency of the contractions. Some depressing effect, never marked, was observed in 5 cases, but a stimulating effect was never observed (Fig. 2B ). All 16 rats were represented in this study. The results appear in Table 1 .
Effect of pitocin: Pitocin was observed to increase three measurable qualities of uterine activity: frequency of contractions, height of contractions, and tone. In Table 1 various strengths of pitocin are expressed as the ratio of the number of contractions in a given interval after the addition of pitocin to the number in an equal interval before pitocin was added. Similarly (Table 3) , the increase in height of contractions is expressed as the quotient obtained by dividing the average height of contractions after the addition of pitocin by the average height before adding pitocin. The increase in tone was measured directly in millimeters, but is omitted as unimportant. It is evident from Table 1 and, more clearly, from Table 2 , that the ability of pitocin to increase the frequency of uterine con- Tables 1 and 2 were measured by dividing the number of contractions in an interval after the addition of manganese with the num- ber in a similar interval in the presence of pitocin but before manganese had been added. In the same manner, the height of contractions after manganese was compared with that before manganese had been added. Increases in tone were measured in millimeters but are not presented, since they did not differ materially from one group to another but were greater, as would be expected, with the higher concentrations of pitocin and manganese. Since the increases in the frequency of contractions produced by adding manganese are here expressed as ratios of the effect of pitocin plus manganese to the effect of pitocin alone, the figure represent- ing this ratio would not be expected to change from one experiment to another tunless the effect of manganese varied independently of the effect of pitocin. Table 2 shows that there is no significant difference in this figure in the four groups of rats. This is in striking contrast to the differences between the groups in their response to pitocin alone. It leads to the conclusion that the effect of manganese in such experiments varies directly with the effect of pitocin. In general, it may be said that whenever pitocin has established uterine contractions in any of the groups studied, non-toxic doses of manganese increase either the frequency or the height of the contractions or both. The magnitude of this effect varies directly with the response previously produced by the pitocin. Increasing the concentration of manganese increases the effect, up to a concentration of 0.8 to 1 mg. % of MnC12, above which level toxic effects gradually become evident, as later described.
The ability of manganese to enhance the activity of the pitocintreated uterus can be demonstrated, under favorable conditions, for initial concentrations of MnCI2 as low as 0.02 mg. % (Figs. 3 and   4 ). This represents a concentration of manganese of only 0.008 mg. %, less than half that which occurs in the blood after ingestion of 0.77 gm. of manganese in a highly insoluble form, and even less than the normal blood level of manganese. In the course of the experiments, the effect of MnCl2 in concentrations of only 0.02 mg. % was demonstrated 15 times on the uteri of 9 different rats with concentrations of pitocin varying from 1:10,000 to 1:500.
In concentrations of only 0.04 mg. % of MnCl2, manganese was shown in 36 experiments, involving 24 uterine horns of 15 rats, to increase the response of the uterus to pitocin in concentrations varying from 1:10,000 to 1:500 (Figs. 3 and 4) .
As the concentrations of manganese were increased, more dramatic results were obtained. Examples of these are illustrated in Figures  3 and 4 .
Toxic effects of manganese are observed as the concentration of Observations with other drugs: The following additional observations bear upon the underlying mechanism of manganese action. Their significance will become evident in the discussion to follow. Magnesium. Tyrode's solution was shown to depress the spontaneous activity of the uterus (Fig. 5B) . This effect must be attributed to the presence of 10 mg. 7o of magnesium in the solution (Fig. SC) . In Tyrode's solution manganese did not exhibit its characteristic action, that of increasing the response of the uterus to pitocin (Figs. SA and SD) . Equal concentrations of pitocin produced much greater response in the uterus in a medium of Tyrode's solution than in Ringer-Locke solution. This is evident in the comparison of Figs. 5A and 5D with 4B. These responses to pitocin in Tyrode's solution were comparable to those of the uteri, in RingerLocke solution, subject to the action of non-toxic doses of manganese and small toxic doses (2 or 3 mg. %), as is evident in the comparison of Fig. SA with Fig. 3 and similar records.
Epinephrine, in concentrations as low as 1:10,000,000, relaxed the rat uterus, even in the presence of toxic doses of manganese acting with concentrations of pitocin as high as 1:500 and above (Fig. 5A) .
A tropine, 1 mg. %o, did not abolish or appreciably decrease the effect of manganese with pitocin.
Barium chloride produced regular contractions in the uterus, in concentrations of 1 and 2 mg. %, which are not affected by the addition of manganese ( Fig. 2A) . Thiamin chloride,* in concentrations of from 0.0001 to 0.3 mg. %o had no apparent effect on the response of the uterus to pitocin, either in the presence or absence of manganese.
Oxygen, 100 per cent, substituted for the air bubbling through the bath, was observed to produce its classical effect, increasing the frequency of the uterine contractions while decreasing their amplitude. This effect was noted whether the uterus was contracting spontaneously or after stimulation with pitocin.
Sodium chloride, in a concentration calculated to contain the same number of chloride ions as 0.8 mg. % MnCl2 (0.74 mg. % NaCI), had no effect on the pitocin-treated uterus.
Discussion
The evidence detailed above shows that concentrations of MnCI2 below 1 mg. % do not materially alter the spontaneous contractions * Generously provided by Dr. Molitor of Merck and Company.
of the uterus, but they do greatly enhance the response of the uterus to pitocin. That this action of MnCl2 is due to the manganese and does not depend on the chloride fraction is shown by the tests with NaCl. Exactly how manganese acts is not yet clear, but much may be inferred.
Manganese, itself, apparently does not stimulate the uterus, but acts only in conjunction with some other particular substance which does stimulate it. Pitocin is such a substance. Barium chloride apparently is not, nor is the substance, nature unknown, which is responsible for the spontaneous contractions of the uterus. Attempts to produce regular contractions with histamine were unsuccessful, but it appeared that manganese did not enhance the effect of this drug.
The stimulating effect of manganese with pitocin is not through either division of the autonomic nervous system. The fact that epinephrine relaxes the rat uterus eliminates an adrenergic mechanism, while atropine, in concentrations more than sufficient to paralyze cholinergic activity, did not prevent the usual manganese effect.
Manganese, in this case, is apparently uninfluenced by thiamin, since the addition of thiamin neither enhances the effect of manganese nor decreases the toxic effects of high concentrations of manganese.
In view of the fact that the role of manganese as a catalyst of cellular oxidative processes is so well established, and because that function is so fundamental that it may well underlie all the more general effects of manganese which have been observed and reported, it seems logical to interpret the manganese effect here observed in terms of that known property. Arguing for this stand is the remarkably close parallel between the concentrations of MnCl2 effective in this experiment and those found by Sato to affect tissue respiration. Our experiments show that concentrations of MnCl2 below 1 mg. % markedly increase the response of the uterus to pitocin, that larger doses are ineffective in increasing this response further (except that early toxic effects operating with high concentrations of pitocin imitate increased stimulation), and that at concentrations at and above 5 mg. % the uterus is paralyzed. In Sato's experiments concentrations of 1 mg. % MnCl2 stimulated tissue respiration, higher concentrations decreased it and concentrations of 5 mg. % and above completely deranged tissue oxidations. Such a close parallel of results cannot be ignored.
The classical effects of increasing oxygen tension are seen to have some qualitites in common with the effects of manganese, notably an increased tonus and increased frequency of contractions when pitocin is present, but they differ greatly in that oxygen affects spontaneous contractions as much or more than it does contractions excited by pitocin and in that it does not increase, but tends to decrease, the height of contractions. It is not surprising that supplying extra oxygen does not have an effect identical with supplying a factor presumably catalyzing some one phase of cell respiration.
That manganese and pitocin seem to be more effective in experiments with the uteri of rats lacking in thyroid hormone and in those kept on a diet deficient in manganese and iodine lends support to the theory that their effect is due to an activity as oxidative catalysts, because it might be expected that the addition of catalysts would be more effective in the existence of a lack of such factors (and thyroxine is probably such a factor) than in the presence of essentially normal oxidative processes.
An interesting question is raised by consideration of a report recently published by Fraser"9 describing experiments which show that magnesium increases the sensitivity of the rat uterus to both the pressor and oxytocic hormones of the posterior pituitary. Concentrations as low as 0.1 mg. % were found to be effective, the maximal sensitization occurring at 2 to 5 mg. % with the oxytocic fraction. Concentrations above these values depressed the sensitivity of the uterus. Magnesium appeared to depress rather than enhance the reaction of the uterus to histamine and ergobasine tartrate. The striking similarity of these effects of magnesium to those here reported for manganese, plus the observed failure of manganese to act in Tyrode's solution, where magnesium is already present to the extent of 10 mg. %, suggest that the action of the two metals may be very similar. Manganese may be, as magnesium is known to be, an essential element in the chemistry of muscle contraction. The close relationship between manganese and thiamin, now considered essential for the removal of pyruvic acid and, as a secondary consequence, of lactic acid, from the tissues, lends strong support to such a belief.' 15, 53 How manganese and magnesium act to increase the response of the uterus to pitocin can only be surmised, since the chemical nature and mechanism of action of pitocin are still unknown. Under some conditions, these metals are known to act as enzyme catalysts. For this reason, and because they do not increase spontaneous contractions or the contractions produced by histamine, barium chloride, or ergotamine tartrate, it is suggested that here, too, they act as enzyme catalysts and that pitocin is immediately concerned in the reaction, possibly itself an enzyme or an essential catalyst for an enzyme accelerating metabolism in uterine muscle. If this could be established, it might serve to unite into one harmonious theory two observations of fact, namely, that manganese stimulates tissue oxidative processes and that exactly similar concentrations of manganese increase the response of the uterus to pitocin.
How manganese may act to relieve dysmenorrhea, assuming that it does, is equally problematical. It is quite reasonable to suppose, since manganese has here been shown to act (with pitocin) directly on the uterine muscle and not through the autonomic nervous system, that manganese (with pitocin) would have an action on the human uterus comparable to that observed on the rat uterus. Assuming, then, the presence in the blood, at least during menstruation, of some posterior pituitary hormone or similar substance, the oral ingestion of manganese in sufficient amount to elevate the blood manganese level could enhance the action of this substance, facilitating the contraction of the uterus. It has been suggested that such facilitation of contraction by manganese (with pitocin) is accomplished by improving tissue respiration. This action would necessarily involve the correction of that state of depressed oxidative processes earlier proposed as the underlying cause of the pain of dysmenorrhea.
If the success Martin claimed for manganese in the treatment of other menstrual disturbances29 could be confirmed, this same view of the action of manganese might explain that success. Martin's insight into the problem is reflected in his opinion, expressed over half a century ago, that". . . its [manganese] action is prompt, and direct in bringing the uterus and appendages into a normal state of menstrual tonicity."
The role of the thyroid hormone in dysmenorrhea has not been disclosed by this investigation. Whether it acts directly on the uterine muscle as an oxidative catalyst or through the ovary in some manner, or through the pituitary, possibly to increase the output of some oxytocic hormone, can only be conjectured.
We may be sure that, even if manganese therapy is effective in relieving dysmenorrhea, failure will attend the improper use of the drug. Indeed, improper use may have been responsible for its fall-ing from favor. Knowledge that it is poorly absorbed, rapidly removed from the blood stream, and most effective in concentrations around 0.8 mg. % of MnCl2 should suggest to clinicians the use of manganese chloride instead of the dioxide, in frequent small doses instead of infrequent, large ones, the dose to be determined, at least in the beginning, by the blood manganese levels attained. It might even prove beneficial to supplement manganese medication with small amounts of pitocin.
In view of its auxiliary oxytocic property, herein demonstrated, it seems appropriate to suggest further the use of manganese with pitocin in the induction of labor, with the understanding that great caution should attend the first trials of this combination.
Summary
The hypothesis is proposed that dysmenorrhea, like many other forms of visceral pain, is closely related to impaired tissue respiration. When not caused by actual anoxia it may well be attributed to failure of some part of the enzyme-activated oxidation-reduction system of uterine muscle.
Experiments are described which show that MnCl2, in concentrations of less than 1 mg. %, increases the response of the rat uterus to pitocin, this effect varying directly with the original effect of pitocin on the uterus. Similar concentrations of MnCl2 have no effect on the spontaneous contractions of the uterus or on those produced by barium chloride. Concentrations of MnCI2 above 1 mg. % are shown to depress uterine contractions, regardless of their origin.
The uteri of thyroidectomized rats and of rats deprived of both manganese and iodine were more responsive to pitocin and subsequently to manganese than those of normal rats. The uteri of manganese-deficient rats behaved essentially the same as those of the controls.
The dose of manganese required to increase tissue oxidation (Sato) agrees with that needed to increase the response of the uterus to pitocin. A striking similarity to the action of magnesium is observed. The suggestion is made that pitocin is a respiratory enzyme or catalyst involved in the metabolism of uterine muscle and is in turn catalyzed by manganese (or magnesium, etc.).
It is concluded that the alleged effectiveness of manganese in relieving dysmenorrhea may well depend on an interaction with pito-cin or some similar hormone to improve the internal respiration of uterine muscle. Certain suggestions are made relevant to the clinical use of the drug. 
